| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $584,616 ) |
| | 2022 | 2022 | O.N. DIAGNOSTICS, LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R01AR074958 | Clinical Biomechanics of Hip Fracture | 000 | 3 | NIH | 3/31/2022 | $584,616 |
| | 2022 | 2019 | O.N. DIAGNOSTICS, LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R44AR064613 | Pre-Operative Assessment of Fusion-Related Bone Failure | 000 | 3 | NIH | 12/28/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $600,162 ) |
| | 2021 | 2021 | O.N. DIAGNOSTICS, LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R01AR074958 | Clinical Biomechanics of Hip Fracture | 002 | 2 | NIH | 6/9/2021 | $43,310 |
| | 2021 | 2021 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R01AR074958 | Clinical Biomechanics of Hip Fracture | 001 | 2 | NIH | 3/12/2021 | $556,852 |
| | 2021 | 2020 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R01AR074958 | Clinical Biomechanics of Hip Fracture | 000 | 1 | NIH | 2/16/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $647,058 ) |
| | 2020 | 2020 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R01AR074958 | Clinical Biomechanics of Hip Fracture | 000 | 1 | NIH | 4/13/2020 | $647,058 |
|
| Issue Date FY: 2019 ( Subtotal = $578,277 ) |
| | 2019 | 2019 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R44AR064613 | Pre-Operative Assessment of Fusion-Related Bone Failure | 000 | 3 | NIH | 8/13/2019 | $578,277 |
|
| Issue Date FY: 2018 ( Subtotal = $814,222 ) |
| | 2018 | 2018 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R44AR064613 | Pre-Operative Assessment of Fusion-Related Bone Failure | 000 | 2 | NIH | 9/11/2018 | $814,222 |
| | 2018 | 2016 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R44AR057616 | Robust BCT for Clinical Use - Phase II | 000 | 5 | NIH | 5/21/2018 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $0 ) |
| | 2017 | 2014 | O N DIAGNOSTICS LLC | 2150 SHATTUCK AVE STE 610 | BERKELEY | CA | 94704-1347 | ALAMEDA | USA | R43AR064613 | Pre-Operative Assessment of Fusion-Related Bone Failure | 000 | 1 | NIH | 11/3/2016 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $600,000 ) |
| | 2016 | 2016 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR057616 | Robust BCT for Clinical Use - Phase II | 000 | 5 | NIH | 4/14/2016 | $600,000 |
|
| Issue Date FY: 2015 ( Subtotal = $600,000 ) |
| | 2015 | 2015 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR057616 | Robust BCT for Clinical Use - Phase II | 000 | 4 | NIH | 5/19/2015 | $600,000 |
|
| Issue Date FY: 2014 ( Subtotal = $825,000 ) |
| | 2014 | 2014 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR057616 | Robust BCT for Clinical Use - Phase II | 000 | 3 | NIH | 5/6/2014 | $600,000 |
| | 2014 | 2014 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R43AR064613 | Pre-Operative Assessment of Fusion-Related Bone Failure | 000 | 1 | NIH | 9/16/2014 | $225,000 |
|
| Issue Date FY: 2010 ( Subtotal = $888,138 ) |
| | 2010 | 2010 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 004 | 3 | NIH | 8/11/2010 | $343,961 |
| | 2010 | 2010 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R43AR057616 | ROBUST BCT FOR CLINICAL USE | 000 | 2 | NIH | 8/11/2010 | $350,000 |
| | 2010 | 2010 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 001 | 2 | NIH | 3/9/2010 | $194,177 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 003 | 2 | NIH | 3/9/2010 | -$194,177 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 003 | 2 | NIH | 3/9/2010 | $0 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 000 | 2 | NIH | 3/3/2010 | $0 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 000 | 2 | NIH | 3/3/2010 | $194,177 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 002 | 2 | NIH | 3/9/2010 | -$216,555 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 002 | 2 | NIH | 3/9/2010 | $216,555 |
| | 2010 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 002 | 2 | NIH | 3/9/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $570,056 ) |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 001 | 2 | NIH | 9/28/2009 | -$216,555 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 001 | 2 | NIH | 9/28/2009 | $216,555 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 001 | 2 | NIH | 9/28/2009 | $0 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R43AR057616 | ROBUST BCT FOR CLINICAL USE | 001 | 1 | NIH | 7/29/2009 | $350,000 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R43AR057616 | ROBUST BCT FOR CLINICAL USE | 000 | 1 | NIH | 7/27/2009 | $350,000 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 000 | 2 | NIH | 9/22/2009 | $3,501 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R44AR052234 | CLINICAL VALIDATION OF BCT - PHASE II | 000 | 2 | NIH | 9/22/2009 | $216,555 |
| | 2009 | 2009 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704-1135 | ALAMEDA | USA | R43AR057616 | ROBUST BCT FOR CLINICAL USE | 001 | 1 | NIH | 7/29/2009 | -$350,000 |
|
| Issue Date FY: 2007 ( Subtotal = $102,320 ) |
| | 2007 | 2007 | O N DIAGNOSTICS LLC | 64 SHATTUCK SQUARE | BERKELEY | CA | 94704 | ALAMEDA | USA | R43AR052234 | CLINICAL VALIDATION OF BCT | 000 | 1 | NIH | 6/1/2007 | $102,320 |
|
|
